Express Diagnostics is honored to receive the endorsement of NNOAC for our DrugCheck line of rapid screening devices. NNOAC’s endorsement demonstrates the value they see in providing reliable onsite drugs of abuse screening options for officers.
Blue Earth, Minn. (PRWEB) January 25, 2016
Express Diagnostics Int’l (EDI), U.S. manufacturer of DrugCheck® onsite drugs of abuse screening tests, is pleased to announce that the National Narcotic Officers’ Associations’ Coalition (NNOAC) has endorsed the use of DrugCheck test devices. NNOAC is a national organization that advocates for narcotic officers’ concerns regarding legislation, drug enforcement policy, and research.
“NNOAC members and police departments across the nation are using DrugCheck screening devices. They produce quick results, providing officers with reliable drug identification information right on the spot,” says Bob Bushman, president of NNOAC. “DrugCheck rapid tests are an important technological advance that improve law enforcement’s ability to protect our communities and keep our highways safe. They are easy to use and, just as importantly, affordable.”
“Express Diagnostics is honored to receive the endorsement of NNOAC for our DrugCheck line of rapid screening devices,” says Rich Strasser, COO of Express Diagnostics. “NNOAC’s endorsement demonstrates the value the organization sees in providing reliable onsite drugs of abuse screening options for officers nationwide.”
Adds Strasser, “In light of the increased attention being placed upon drugged driving across the country, EDI has partnered with NNOAC to promote drug abuse recognition training and roadside testing options for officers across the U.S.”
Express Diagnostics will participate in NNOAC’s 2016 DC Delegate Meeting, January 30 through February 4, in Washington, D.C.
Learn more at drugcheck.com/nnoac.html.
About the NNOAC
The National Narcotic Officers’ Associations’ Coalition is comprised of 40 individual state narcotic associations and the Territory of Puerto Rico, representing more than 55,000 law enforcement officers nationwide. It serves as an umbrella organization, coordinating the efforts of these associations and monitoring legislation and policy initiatives in Washington, D.C.
About Express Diagnostics Int'l
Express Diagnostics, FDA-registered and ISO 13485:2003-certified manufacturer of DrugCheck onsite drugs of abuse screening devices, distributes in vitro diagnostic (IVD) devices to over 65 countries. The company was first to market with instant tests for urine alcohol, K2/synthetic cannabis, and GHB (gamma hydroxybutyric acid). With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services.